 Connection
M Cave to Drug Resistance, Bacterial
This is a "connection" page, showing publications M Cave has written about Drug Resistance, Bacterial.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.083 |
|
|
|
-
Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med. 2003 Sep 18; 349(12):1149-56.
Score: 0.055
-
Hazb?n MH, Bobadilla del Valle M, Guerrero MI, Varma-Basil M, Filliol I, Cavatore M, Colangeli R, Safi H, Billman-Jacobe H, Lavender C, Fyfe J, Garc?a-Garc?a L, Davidow A, Brimacombe M, Le?n CI, Porras T, Bose M, Chaves F, Eisenach KD, Sifuentes-Osornio J, Ponce de Le?n A, Cave MD, Alland D. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother. 2005 Sep; 49(9):3794-802.
Score: 0.016
-
Li Q, Whalen CC, Albert JM, Larkin R, Zukowski L, Cave MD, Silver RF. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect Immun. 2002 Nov; 70(11):6489-93.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|